[Beta-adrenergic blocking agents in the treatment of myxedema in patients intolerant to substitution].
D004342:Drug Hypersensitivity; D006801:Humans; D009230:Myxedema / Q000188:drug therapy*; D013565:Sympatholytics / Q000627:therapeutic use*; D013963:Thyroid Hormones / Q000009:adverse effects*
D013565:Sympatholytics; D013963:Thyroid Hormones
Béta-adrenerg blockolók a substitutiót rosszul türö myxoedemás betegek kezelésében.